Abstract
Background
There is an increased prevalence of subclinical hypothyroidism (SCH) in patients with obesity. It is unclear if this biochemical abnormality may be a secondary phenomenon of obesity or a real hypothyroid state.
Methods
A retrospective study of all the morbidly obese patients undergoing laparoscopic sleeve gastrectomy as bariatric procedure between October 2007 and November 2012 was performed. Weight loss, body mass index (BMI) and excess weight loss, baseline glucose, lipid profiles, and TSH levels were obtained before operation and postoperative determinations at 3, 6, and 12 months after surgery.
Results
Sixty patients were included. Prevalence of subclinical hypothyroidism was 16.7 % preoperatively, 10 % at 3 months, 3.3 % at 6 months, and 1.7 % at 12 months. A significant correlation could be established between TSH decrease and weight loss at 12 months (Pearson 0.603; p = 0.007). TSH decrease showed a significant correlation with glucose and glycated hemoglobin decrease from 6th month onwards. Referring to lipid profile, an association of TSH decrease with total cholesterol, LDL cholesterol, or HDL cholesterol could not be determined. A significant association between TSH decrease and triglycerides and cardiovascular risk index triglycerides/HDL cholesterol reductions could also be established 12 months after surgery.
Conclusions
SCH is usually corrected after bariatric surgery, while there are no significant changes in total or LDL cholesterol. This suggests that, in morbidly obese subjects, SCH is, in most patients, just a consequence of the abnormal fat accumulation and not a real hypothyroid state.
Similar content being viewed by others
References
Tuzcu A, Bahceci M, Gokalp D, et al. Subclinical hypothyroidism may be associated with elevated high-sensitive C-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocrine J. 2005;52:89–94.
Vanderpump M. Subclinical hypothyroidism: the case against treatment. Trends Endocrinol Metab. 2003;14:262–6.
Diaz-Olmos R, Nogueira AC, Penalva DQF, et al. Frequency of subclinical thyroid dysfunction and risk factors for cardiovascular disease among women at a workplace. Sao Paulo Med J. 2010;128:18–23.
De Pergola G, Ciampolillo A, Paolotti S, et al. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrino (Oxf). 2007;67:265–9.
Biondi B, Palmieri EA, Lombardi G, et al. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. 2002;137:904–14.
Gaziano JM, Hennekens CH, O’Donnell CJ, et al. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96:2520–5.
Mehta S, Mathur D, Chaturvedi M, et al. Thyroid hormone profile in obese subjects—a clinical study. J Indian Med Assoc. 2001;99:260–72.
Roelfsema F, Veldhuis JD. Thyrotropin secretion patterns in health and disease. Endocrine Rev 2013. doi:10.1210/er.2012-1076.
Nyrnes A, Jorde R, Sundsfjord J. Serum TSH is positively associated with BMI. Int J Obes (Lond). 2006;30:100–5.
Fox CS, Pencina MJ, D’Agostino RB, et al. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med. 2008;168:587–92.
Chikunguwo S, Brethauer S, Nirujogi V, et al. Influence of obesity and surgical weight loss on thyroid hormone levels. Surg Obes Relat Dis. 2007;3:631–5.
Marzullo P, Minocci A, Tagliaferri MA, et al. Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal and weight-related determinants. J Clin Endocrinol Metab. 2010;95:3965–72.
Rotondi M, Leporati P, Rizza MI, et al. Raised serum TSH in morbid-obese and non-obese patients: effect of the circulating lipid profile. Endocrine 2013. doi:10.1007/S12020-013-9928-8.
Frias Lopez MC, Tárraga Lopez PJ, Rodriguez Montes JA, et al. Hipotiroidismo subclínico y factores de riesgo cardiovascular. Nutr Hosp. 2011;26:1355–62.
Velkoska Nakova V, Krstevska B, Bosevski M, et al. Dyslipidemia and hypertension in patients with hypothyroidism. Prilozi. 2009;30:93–102.
Vierhapper H, Nardi A, Grosser P. Prevalence of paradoxically normal serum cholesterol in morbidly obese women. Metabolism. 2000;49:607–10.
Ruiz-Tovar J, Oller I, Tomas A, et al. Midterm impact of sleeve gastrectomy, calibrated with a 50-Fr bougie, on weight loss, glucose hemostasis, lipid profiles and comorbidities in morbidly obese patients. Am Surg. 2012;78:969–74.
Galofre JC, Pujante P, Abreu C, et al. Relationship between thyroid-stimulating hormone and insulin in euthyroid obese men. Ann Nutr Metab. 2008;53:188–94.
Kouidhi S, Berhouma R, Ammar M, et al. Relationship of thyroid function with obesity and type 2 diabetes in euthyroid Tunisian subjects. Endocr Res. 2013;38:15–23.
Celik C, Abali R, Tasdemir N, et al. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome? Gynecol Endocrinol. 2012;28:615–8.
Proces S, Delgrange E, Vander Borght TV, et al. Minor alterations in thyroid-function tests associated with diabetes mellitus and obesity in outpatients without known thyroid illness. Acta Clin Belg. 2001;56:86–90.
Velija-Asimi Z, Karamehic J. The effects of treatment of subclinical hypothyroidism on metabolic control and hyperinsulinemia. Med Arh. 2007;61:20–1.
Conflict of Interest
All authors (Jaime Ruiz-Tovar, MD, PhD; Evangelina Boix, MD, PhD; Isabel Galindo, MD; Lorea Zubiaga, MD; María Diez, MD; Antonio Arroyo, MD, PhD; and Rafael Calpena, MD, PhD) declare that they have no conflict of interests in the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ruiz-Tovar, J., Boix, E., Galindo, I. et al. Evolution of Subclinical Hypothyroidism and its Relation with Glucose and Triglycerides Levels in Morbidly Obese Patients After Undergoing Sleeve Gastrectomy as Bariatric Procedure. OBES SURG 24, 791–795 (2014). https://doi.org/10.1007/s11695-013-1150-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-013-1150-5